IMCR
Immunocore Holdings plc
NASDAQ · Healthcare · Biotechnology · GB
$36.13
−3.83%Margins
Gross margin
98.8%
EBITDA margin
4.0%
EBIT margin
-4.3%
Net margin
-2.3%
FCF margin
-15.5%
-2.2%
Return on equity
-0.8%
Return on assets
-2.0%
Return on invested capital
0.37x
Asset turnover
-$56.3M
Cash from operations
$17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026